Kolexia
Savignoni Alexia Santé publique
Savignoni Alexia
Santé publique
Clcc Institut Curie
Paris, France
113 Activités
220 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Rétinoblastome Métastase tumorale Récidive tumorale locale Tumeurs de la rétine Mélanome Lymphomes Carcinome canalaire du sein Carcinomes

Collaborateurs

Voir plus
Pierga Jean-Yves
Pierga Jean-Yves
Clcc Institut Curie, Paris, France
Kirov Youlia
Kirov Youlia
Clcc Institut Curie, Paris, France
Gregoire-Cassoux Nathalie
Gregoire-Cassoux Nathalie
Clcc Institut Curie, Paris, France
Fourquet Alain
Fourquet Alain
Clcc Institut Curie, Paris, France

Industries

Voir plus
Roche
8 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Management of second ipsilateral breast tumor event: An advocacy for a randomized trial.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   11 janvier 2024
Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR): Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. A Qualitative Cross-sectional Study of Professionals, Patients, Parents of Sick Children, and Expert Patients, in the Context of Triple Negative or Luminal B Breast Cancer, Metastatic Uveal Melanoma and Pediatric Cancers.
Essai Clinique (Institut Curie)   28 novembre 2023
PROGNOSTIC VALUE OF MOLECULAR MARKERS IN UNILATERAL RETINOBLASTOMA TREATED BY FIRST-LINE ENUCLEATION
Abstracts from the 55th Congress of the International Society of Paediatric Oncology (SIOP) October 11–14, 2023   02 novembre 2023
COMET: Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab (AVASTIN ®) in Combination With Weekly Paclitaxel Chemotherapy in First Line Treatment Patients With Metastatic Breast Cancer
Essai Clinique (Unicancer)   25 janvier 2023
Early together: A randomized phase III study of early palliative care in metastatic uveal melanoma (MUM).
2022 ASCO Annual Meeting I   02 juin 2022
Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods Study.
JMIR research protocols   12 janvier 2022
Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project.
PloS one   15 septembre 2021
Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study.
Ophthalmology. Retina   14 mai 2021
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival.
NPJ precision oncology   28 avril 2021
Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.
JAMA ophthalmology   22 janvier 2021